Category: Stock Market News

Apple Inc. could boost its stock buyback program by $40 billion to $50 billion, and “comfortably” raise its dividend by 10% to 15%, when it announces its shareholder-return plans next month, analyst Amit Daryanani wrote in a note to clients Monday. The company could “implicitly commit” to returning all of its annual free cash flow to investors, given that it has $200 billion in cash, Daryanani said. Apple is expected to update its capital allocation program when it reports fiscal second-quarter results on April 19. He reiterated his outperform rating on Apple’s stock, and his $130 price target, which is 23% above Thursday’s closing price of $105.67. The stock, which tacked on 0.3% in premarket trade, has gained 0.4% year to date, compared with a 0.5% gain in the Dow Jones Industrial Average.

Market Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move. Visit MarketWatch.com for more information on this news.

…read more

From:: Stock Market News

Apple Inc. could boost its stock buyback program by $40 billion to $50 billion, and “comfortably” raise its dividend by 10% to 15%, when it announces its shareholder-return plans next month, analyst Amit Daryanani wrote in a note to clients Monday. The company could “implicitly commit” to returning all of its annual free cash flow to investors, given that it has $200 billion in cash, Daryanani said. Apple is expected to update its capital allocation program when it reports fiscal second-quarter results on April 19. He reiterated his outperform rating on Apple’s stock, and his $130 price target, which is 23% above Thursday’s closing price of $105.67. The stock, which tacked on 0.3% in premarket trade, has gained 0.4% year to date, compared with a 0.5% gain in the Dow Jones Industrial Average.

Market Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move. Visit MarketWatch.com for more information on this news.

…read more

From:: Stock Market News

Apple Inc. could boost its stock buyback program by $40 billion to $50 billion, and “comfortably” raise its dividend by 10% to 15%, when it announces its shareholder-return plans next month, analyst Amit Daryanani wrote in a note to clients Monday. The company could “implicitly commit” to returning all of its annual free cash flow to investors, given that it has $200 billion in cash, Daryanani said. Apple is expected to update its capital allocation program when it reports fiscal second-quarter results on April 19. He reiterated his outperform rating on Apple’s stock, and his $130 price target, which is 23% above Thursday’s closing price of $105.67. The stock, which tacked on 0.3% in premarket trade, has gained 0.4% year to date, compared with a 0.5% gain in the Dow Jones Industrial Average.

Market Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move. Visit MarketWatch.com for more information on this news.

…read more

From:: Stock Market News

Apple Inc. could boost its stock buyback program by $40 billion to $50 billion, and “comfortably” raise its dividend by 10% to 15%, when it announces its shareholder-return plans next month, analyst Amit Daryanani wrote in a note to clients Monday. The company could “implicitly commit” to returning all of its annual free cash flow to investors, given that it has $200 billion in cash, Daryanani said. Apple is expected to update its capital allocation program when it reports fiscal second-quarter results on April 19. He reiterated his outperform rating on Apple’s stock, and his $130 price target, which is 23% above Thursday’s closing price of $105.67. The stock, which tacked on 0.3% in premarket trade, has gained 0.4% year to date, compared with a 0.5% gain in the Dow Jones Industrial Average.

Market Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move. Visit MarketWatch.com for more information on this news.

…read more

From:: Stock Market News

Imax Corp. said Monday the Warner Bros. Pictures’ “Batman v Superman: Dawn of Justice” made a record $36 million on 945 Imax screens around the world in its opening weekend. That’s the biggest box office for a film released outside of key summer and Christmas holiday periods, Imax said in a statement. The film is now the third-biggest global opening for Imax after “Star Wars: The Force Awakens,” which earned $47.5 million in its opening weekend, and “Jurassic World,” which earned $44.1 million. In the U.S. alone, the film earned $18 million from 557 Imax screens to set a March record. Time Warner shares were not yet active in premarket trade, but are up 8% in the year so far, while the S&P 500 has lost 0.4%.

Market Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move. Visit MarketWatch.com for more information on this news.

…read more

From:: Stock Market News

Imax Corp. said Monday the Warner Bros. Pictures’ “Batman v Superman: Dawn of Justice” made a record $36 million on 945 Imax screens around the world in its opening weekend. That’s the biggest box office for a film released outside of key summer and Christmas holiday periods, Imax said in a statement. The film is now the third-biggest global opening for Imax after “Star Wars: The Force Awakens,” which earned $47.5 million in its opening weekend, and “Jurassic World,” which earned $44.1 million. In the U.S. alone, the film earned $18 million from 557 Imax screens to set a March record. Time Warner shares were not yet active in premarket trade, but are up 8% in the year so far, while the S&P 500 has lost 0.4%.

Market Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move. Visit MarketWatch.com for more information on this news.

…read more

From:: Stock Market News

Oxigene Inc. said its treatment for pancreatic cancer, CA4P, was granted orphan drug status by the European Commission. That gives the company 10 years of marketing exclusivity in European Union member countries if the product is approved. Earlier this year, CA4P was granted the orphan drug designation for neuroendocrine tumors (NETs) in the U.S. “This designation represents another successful step as we execute on our strategy of bolstering the proprietary position of CA4P in the potential indications in which we are most interested,” said Chief Executive William Schwieterman. “Separately, we continue to expect final data from our phase 2a clinical trial of CA4P in NETs to be available later in 2016.” The stock has slumped 11% so far this year and 53% over the last 12 months. The S&P 500 has slipped 0.4% year to date and 1.1% the past year.

Market Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move. Visit MarketWatch.com for more information on this news.

…read more

From:: Stock Market News

Pineapple Express Inc. said Larry Flynt, the founder of publisher of Hustler Magazine, has bought 100,000 shares of the cannabis business developer for $100,000. Flynt will be restricted from trading the shares for a defined period of time. “We are fortunate to have such an amazing investor by our side,” said Chief Executive Matthew Feinstein. “Knowing that Mr. Flynt has made an investment in our company provides impetus for everyone at headquarters to surpass expectations and deliver excellent results.” The company’s common stock, which trades on the OTC Pink exchange, closed Thursday at $10.10. It has rocketed six fold since closing at $1.68 on Dec. 31.

Market Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move. Visit MarketWatch.com for more information on this news.

…read more

From:: Stock Market News

Shares of Hologic Inc. and Centene Corp. ticked higher in the extended session Thursday after S&P Dow Jones Indices said the companies will join the S&P 500 index . Hologic shares rose 2% to $35.04, and Centene shares advanced 1.5% to $64.71 after hours. Medical-device maker Hologic replaces Pepco Holdings Inc., which was acquired by Exelon Corp. , and health insurer Centene replaces Ensco PLC . The changes take effect on Tuesday.

Market Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move. Visit MarketWatch.com for more information on this news.

…read more

From:: Stock Market News

GameStop Corp. shares fell more than 6% late Thursday after the company reported 2016 earnings expectations slightly below Wall Street consensus. The game retailer reported adjusted net earnings of $251.6 million, or $2.40 a share, in the fourth quarter, compared with adjusted net earnings of $235.5 million, or $2.15 a share, in the prior-year quarter. Sales reached $3.53 billion in the quarter. Analysts polled by FactSet had expected the company to report adjusted earnings of $2.25 a share on sales of $3.57 billion. GameStop said the stronger dollar will continue to hit its bottom line this year, to the tune of 5 cents a share to 8 cents a share on its full-year earnings. The company said it expects full-year 2016 earnings between $3.90 a share and $4.05 a share, below analyst estimates of $4.08 a share for the year. Shares ended the regular session Thursday down 0.3%.

Market Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move. Visit MarketWatch.com for more information on this news.

…read more

From:: Stock Market News